The High Level of IL-1β in the Serum of ACLF Patients Induces Increased IL-8 Expression in HUC-MSCs and Reduces the Efficacy of HUC-MSCs in Liver Failure

Overview

Journal Stem Cell Res Ther

Publisher Biomed Central

Date 2023 Aug 30

PMID 37649110

Authors

Yong-Hong Wang

Meng-Lan Wang

Ya-Chao Tao

Dong-Bo Wu

En-Qiang Chen

Hong Tang

Affiliations

Soon will be listed here.

Abstract

Background: Stem cells play a therapeutic role mainly through immunoregulation. However, the immunomodulatory function of stem cells may be affected by inflammation-related factors in patients' serum. Therefore, this study aims to investigate the possible mechanism by which acute-on-chronic liver failure (ACLF) patient serum influences the efficacy of hUC-MSCs.

Methods: The serum of surviving and dead ACLF patients was collected to culture hUC-MSCs in vitro, and the hUC-MSCs cultured in the serum of ACLF patients were used to treat acute liver failure (ALF) rats. The therapeutic effect on the rats was evaluated by a survival curve, the transaminase level and liver histopathology. The expression of cytokines in hUC-MSCs was detected by Q-PCR and ELISA.

Results: Serum pretreatment reduced the therapeutic effect of hUC-MSCs on ALF, especially pretreatment in the serum from dead ACLF patients. After hUC-MSCs were cultured in the serum of surviving or dead ACLF patients, the most differentially expressed factor was IL-8. Interfering with the expression of IL-8 in hUC-MSCs can improve the therapeutic effect of hUC-MSCs on ALF. The high level of IL-1β in the serum of dead ACLF patients causes the increased expression of IL-8 in hUC-MSCs through the activation of the NF-κB signaling pathway. Meanwhile, we found that the neutralizing IL-1β in serum from dead ACLF patients can improve the therapeutic effect of hUC-MSCs on ALF.

Conclusion: The high level of IL-1β in ACLF serum can promote the expression of IL-8 in hUC-MSCs through the NF-κB signaling pathway, thus reducing the effect of hUC-MSCs on ALF.

Citing Articles

The Effects of the Pneumonia Lung Microenvironment on MSC Function.

Liu L, Fandino J, McCarthy S, Masterson C, Sallent I, Du S Cells. 2024; 13(18.

PMID: 39329762 PMC: 11430541. DOI: 10.3390/cells13181581.

Deciphering the Role of LncRNAs in Osteoarthritis: Inflammatory Pathways Unveiled.

Hu K, Wen H, Song T, Che Z, Song Y, Song M J Inflamm Res. 2024; 17:6563-6581.

PMID: 39318993 PMC: 11421445. DOI: 10.2147/JIR.S489682.

The Impact of Liver Failure on the Immune System.

Dabrowska A, Wilczynski B, Mastalerz J, Kucharczyk J, Kulbacka J, Szewczyk A Int J Mol Sci. 2024; 25(17).

PMID: 39273468 PMC: 11395474. DOI: 10.3390/ijms25179522.

References

Fu X, Liu G, Halim A, Ju Y, Luo Q, Song A . Mesenchymal Stem Cell Migration and Tissue Repair. Cells. 2019; 8(8). PMC: 6721499. DOI: 10.3390/cells8080784. View

Casulleras M, Zhang I, Lopez-Vicario C, Claria J . Leukocytes, Systemic Inflammation and Immunopathology in Acute-on-Chronic Liver Failure. Cells. 2020; 9(12). PMC: 7762372. DOI: 10.3390/cells9122632. View

Tao Y, Wang M, Chen E, Tang H . Stem Cells Transplantation in the Treatment of Patients with Liver Failure. Curr Stem Cell Res Ther. 2018; 13(3):193-201. DOI: 10.2174/1574888X13666180105123915. View

Ting H, Chen C, Meng E, Cherng J, Chang S, Kao C . Inflammatory Regulation by TNF-α-Activated Adipose-Derived Stem Cells in the Human Bladder Cancer Microenvironment. Int J Mol Sci. 2021; 22(8). PMC: 8069705. DOI: 10.3390/ijms22083987. View

Moon G, Cho Y, Kim D, Sung J, Son J, Kim S . Serum-mediated Activation of Bone Marrow-derived Mesenchymal Stem Cells in Ischemic Stroke Patients: A Novel Preconditioning Method. Cell Transplant. 2018; 27(3):485-500. PMC: 6038038. DOI: 10.1177/0963689718755404. View

Tomescu D, Popescu M, Biancofiore G . Liver transplantation for acute-on-chronic liver failure. Best Pract Res Clin Anaesthesiol. 2020; 34(1):25-33. DOI: 10.1016/j.bpa.2019.12.001. View

Zhang Y, Li Y, Zhang L, Li J, Zhu C . Mesenchymal stem cells: potential application for the treatment of hepatic cirrhosis. Stem Cell Res Ther. 2018; 9(1):59. PMC: 5845383. DOI: 10.1186/s13287-018-0814-4. View

Khanam A, Trehanpati N, Riese P, Rastogi A, Guzman C, Sarin S . Blockade of Neutrophil's Chemokine Receptors CXCR1/2 Abrogate Liver Damage in Acute-on-Chronic Liver Failure. Front Immunol. 2017; 8:464. PMC: 5401894. DOI: 10.3389/fimmu.2017.00464. View

Bonkovsky H, Barnhart H, Foureau D, Steuerwald N, Lee W, Gu J . Cytokine profiles in acute liver injury-Results from the US Drug-Induced Liver Injury Network (DILIN) and the Acute Liver Failure Study Group. PLoS One. 2018; 13(10):e0206389. PMC: 6201986. DOI: 10.1371/journal.pone.0206389. View

10.

Waterman R, Tomchuck S, Henkle S, Betancourt A . A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. PLoS One. 2010; 5(4):e10088. PMC: 2859930. DOI: 10.1371/journal.pone.0010088. View

11.

Baj-Krzyworzeka M, Weglarczyk K, Mytar B, Szatanek R, Baran J, Zembala M . Tumour-derived microvesicles contain interleukin-8 and modulate production of chemokines by human monocytes. Anticancer Res. 2011; 31(4):1329-35. View

12.

Hu C, Wu Z, Li L . Pre-treatments enhance the therapeutic effects of mesenchymal stem cells in liver diseases. J Cell Mol Med. 2019; 24(1):40-49. PMC: 6933358. DOI: 10.1111/jcmm.14788. View

13.

Volarevic V, Nurkovic J, Arsenijevic N, Stojkovic M . Concise review: Therapeutic potential of mesenchymal stem cells for the treatment of acute liver failure and cirrhosis. Stem Cells. 2014; 32(11):2818-23. DOI: 10.1002/stem.1818. View

14.

Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts A . Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell. 2008; 2(2):141-50. DOI: 10.1016/j.stem.2007.11.014. View

15.

Watanabe Y, Tsuchiya A, Seino S, Kawata Y, Kojima Y, Ikarashi S . Mesenchymal Stem Cells and Induced Bone Marrow-Derived Macrophages Synergistically Improve Liver Fibrosis in Mice. Stem Cells Transl Med. 2018; 8(3):271-284. PMC: 6392382. DOI: 10.1002/sctm.18-0105. View

16.

Shi M, Zhang Z, Xu R, Lin H, Fu J, Zou Z . Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients. Stem Cells Transl Med. 2012; 1(10):725-31. PMC: 3659658. DOI: 10.5966/sctm.2012-0034. View

17.

Thiel G, Ulrich M, Mukaida N, Rossler O . Resveratrol stimulation induces interleukin-8 gene transcription via NF-κB. Pharmacol Res. 2018; 134:238-245. DOI: 10.1016/j.phrs.2018.07.003. View

18.

Achudhan D, Liu S, Lin Y, Huang C, Tsai C, Ko C . Antcin K Inhibits TNF-α, IL-1β and IL-8 Expression in Synovial Fibroblasts and Ameliorates Cartilage Degradation: Implications for the Treatment of Rheumatoid Arthritis. Front Immunol. 2022; 12:790925. PMC: 8714747. DOI: 10.3389/fimmu.2021.790925. View

19.

Glass O, Henao R, Patel K, Guy C, Gruss H, Syn W . Serum Interleukin-8, Osteopontin, and Monocyte Chemoattractant Protein 1 Are Associated With Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Hepatol Commun. 2018; 2(11):1344-1355. PMC: 6211321. DOI: 10.1002/hep4.1237. View

20.

Lopez-Castejon G, Brough D . Understanding the mechanism of IL-1β secretion. Cytokine Growth Factor Rev. 2011; 22(4):189-95. PMC: 3714593. DOI: 10.1016/j.cytogfr.2011.10.001. View